Multimodal biomarkers for early detection and immunotherapy assessment in hepatocellular carcinoma: integrating liquid biopsy, AI-based imaging and tumor immune profiling. [PDF]
Zhao Y, Chen X, Zhao H.
europepmc +1 more source
Decoding coupled epigenetic-fragmentomic signals in circulating cell-free DNA for interpretable cancer diagnosis. [PDF]
Wang Y +5 more
europepmc +1 more source
Early multi-cancer detection using liquid biopsy: emerging biomarkers and clinical strategies. [PDF]
Nirob SR +6 more
europepmc +1 more source
Characterization of global cfDNA fragmentomics in Melanoma Patients
J.L. Villanueva-Cañas +8 more
openaire +1 more source
From concept to clinic: emerging paradigms and novel insights into liquid biopsy. [PDF]
Guo W +7 more
europepmc +1 more source
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling
Shallow genome-wide cell-free DNA sequencing holds great promise for noninvasive cancer monitoring by providing reliable copy number alteration (CNA) and fragmentomic profiles.
MS Gynaecologische Oncologie +23 more
core
Emerging Role of ctDNA Fragmentomics and Epigenetic Signatures in the Early Detection, Minimal Residual Disease Assessment, and Precision Monitoring of Renal Cell Carcinoma. [PDF]
Kamli H, Khan NU.
europepmc +1 more source
Circulating Cell-free DNA as a biomarker for radiation-induced injury: From mechanistic insights to clinical translation. [PDF]
Sun Q, Li Y, Yin T, Teng F, Yu J.
europepmc +1 more source
Circulating cell-free mtDNA fragmentomics for early detection of gastric cancer and precancerous lesions. [PDF]
Dang M +17 more
europepmc +1 more source
A machine learning framework combining cfDNA fragmentomics and serum biomarkers for early ovarian cancer detection. [PDF]
Weng W +14 more
europepmc +1 more source

